For patients with airway obstruction, bronchodilator therapy (eg, with some combination of a long-acting beta-adrenergic agonist, a long-acting muscarinic (anticholinergic) antagonist (eg, tiotropium), and a short-acting beta-adrenergic drug as indicated by symptoms and severity of lung obstruction, as used in patients with COPD) can help improve function and quality of life.